98200315 - MICIT

Information

  • Trademark
  • 98200315
  • Serial Number
    98200315
  • Filing Date
    September 27, 2023
    2 years ago
  • Transaction Date
    March 02, 2025
    a year ago
  • Status Date
    December 09, 2024
    a year ago
  • Published for Opposition Date
    July 02, 2024
    a year ago
  • Location Date
    August 27, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MILLER,AMANDA A
  • Attorney Docket Number
    3814.0520000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    O60
  • Owners
Mark Drawing Code
4
Mark Identification
MICIT
Case File Statements
  • GS0091: Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients
  • GS0051: Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer
  • GS0441: Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors
  • GS0101: Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes
  • GS0421: Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy
Case File Event Statements
  • 9/30/2023 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/20/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/28/2024 - a year ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/28/2024 - a year ago
    8 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/11/2023 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/28/2024 - a year ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/28/2024 - a year ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/28/2024 - a year ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/12/2024 - a year ago
    9 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/2/2024 - a year ago
    10 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/2/2024 - a year ago
    11 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/27/2024 - a year ago
    12 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/9/2024 - a year ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/9/2024 - a year ago
    14 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/9/2024 - a year ago
    15 - SOU EXTENSION 1 GRANTED Type: EX1G